After that, this process was repeated in melanoma-related CD8+ T cells with the help of a high-throughput in vitro pharmacologic screening platform, and overexpression of GPX4 can effectively restore the anti-tumor immune effect of T cells [125]. The gene discussed is GPX4; the disease is neoplasm.